Pascal Amedro1,2,3, Helena Huguet4,5, Valerie Macioce4, Raphael Dorka6, Annie Auer7, Sophie Guillaumont6,7, Pascal Auquier8, Hamouda Abassi6,8, Marie-Christine Picot4,5. 1. Pediatric and Congenital Cardiology Department, M3C Regional Reference Center, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France. pascal.amedro@gmail.com. 2. PhyMedExp, University of Montpellier, CNRS, INSERM, Montpellier, France. pascal.amedro@gmail.com. 3. Department of Public Health, Aix-Marseille University, EA 3279 Research Unit, Marseille, France. pascal.amedro@gmail.com. 4. Epidemiology and Clinical Research Department, University Hospital, Montpellier, France. 5. Clinical Investigation Center, INSERM-CIC 1411, University of Montpellier, Montpellier, France. 6. Pediatric and Congenital Cardiology Department, M3C Regional Reference Center, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France. 7. Pediatric Cardiology and Rehabilitation Center, Institut-Saint-Pierre, Palavas-Les-Flots, France. 8. Department of Public Health, Aix-Marseille University, EA 3279 Research Unit, Marseille, France.
Abstract
BACKGROUND: The Pediatric Quality of Life Inventory Version 4.0 (PedsQLTM4.0) is a generic health-related quality of life (HRQoL) questionnaire, widely used in pediatric clinical trials but not yet validated in France. We performed the psychometric validation of the self and proxy PedsQLTM4.0 generic questionnaires for French children aged 8-12 years old. METHODS: This bicentric cross-sectional study included 123 children and their parents with congenital heart disease (CHD) and 97 controls. The psychometric validation method was based on the consensus-based standards for the selection of health measurement instruments (COSMIN). The reliability was tested using the intraclass correlation coefficient (ICC). To evaluate the validity of this scale, content, face, criterion, and construct validity psychometric proprieties were tested. Acceptability was studied regarding questionnaires' completion and the existence of a floor or a ceiling effect. RESULTS: Test-retest reliability intra-class correlation coefficients were mainly in good range (0.49-0.66). Face validity was very good among parents (0.85) and children (0.75). Content validity was good (0.70), despite misinterpretation of some items. In construct validity, each subscale had acceptable internal consistency reliability (Cronbach's α > 0.72 in self-reports, > 0.69 in proxy-reports). In the confirmatory factor analysis, the goodness-of-fit statistics rejected the original structure with 4 factors. The exploratory factor analysis revealed an alternative two-factor structure corresponding to physical and psychological dimensions. Convergent validity was supported by moderate (> 0.41) to high correlations (0.57) between PedsQL and Kidscreeen questionnaires for physical, emotion and school dimensions. The ability of the PedsQL to discriminate CHD severity was better with physical, social and total scores for both self-reports and proxy-reports. CONCLUSIONS: The PedsQLTM4.0 generic self and proxy HRQoL questionnaires found good psychometric properties, with regard to acceptability, responsiveness, validity, and reliability. This instrument appeared to be easy to use and comprehend within the target population of children aged 8 to 12 years old and their parents. TRIAL REGISTRATION: This study was approved by the South-Mediterranean-IV Ethics Committee and registered on ClinicalTrials.gov (NCT01202916), https://clinicaltrials.gov/ct2/show/NCT01202916 .
BACKGROUND: The Pediatric Quality of Life Inventory Version 4.0 (PedsQLTM4.0) is a generic health-related quality of life (HRQoL) questionnaire, widely used in pediatric clinical trials but not yet validated in France. We performed the psychometric validation of the self and proxy PedsQLTM4.0 generic questionnaires for French children aged 8-12 years old. METHODS: This bicentric cross-sectional study included 123 children and their parents with congenital heart disease (CHD) and 97 controls. The psychometric validation method was based on the consensus-based standards for the selection of health measurement instruments (COSMIN). The reliability was tested using the intraclass correlation coefficient (ICC). To evaluate the validity of this scale, content, face, criterion, and construct validity psychometric proprieties were tested. Acceptability was studied regarding questionnaires' completion and the existence of a floor or a ceiling effect. RESULTS: Test-retest reliability intra-class correlation coefficients were mainly in good range (0.49-0.66). Face validity was very good among parents (0.85) and children (0.75). Content validity was good (0.70), despite misinterpretation of some items. In construct validity, each subscale had acceptable internal consistency reliability (Cronbach's α > 0.72 in self-reports, > 0.69 in proxy-reports). In the confirmatory factor analysis, the goodness-of-fit statistics rejected the original structure with 4 factors. The exploratory factor analysis revealed an alternative two-factor structure corresponding to physical and psychological dimensions. Convergent validity was supported by moderate (> 0.41) to high correlations (0.57) between PedsQL and Kidscreeen questionnaires for physical, emotion and school dimensions. The ability of the PedsQL to discriminate CHD severity was better with physical, social and total scores for both self-reports and proxy-reports. CONCLUSIONS: The PedsQLTM4.0 generic self and proxy HRQoL questionnaires found good psychometric properties, with regard to acceptability, responsiveness, validity, and reliability. This instrument appeared to be easy to use and comprehend within the target population of children aged 8 to 12 years old and their parents. TRIAL REGISTRATION: This study was approved by the South-Mediterranean-IV Ethics Committee and registered on ClinicalTrials.gov (NCT01202916), https://clinicaltrials.gov/ct2/show/NCT01202916 .
Entities:
Keywords:
Kidscreen; Patient-reported outcome; Pediatric cardiology; Pediatrics; Psychometric validation; Quality of life
Authors: P Amedro; R Dorka; S Moniotte; S Guillaumont; A Fraisse; B Kreitmann; B Borm; H Bertet; C Barrea; C Ovaert; T Sluysmans; G De La Villeon; M Vincenti; M Voisin; P Auquier; M C Picot Journal: Pediatr Cardiol Date: 2015-05-31 Impact factor: 1.655
Authors: Lidwine B Mokkink; Caroline B Terwee; Dirk L Knol; Paul W Stratford; Jordi Alonso; Donald L Patrick; Lex M Bouter; Henrica Cw de Vet Journal: BMC Med Res Methodol Date: 2010-03-18 Impact factor: 4.615
Authors: P Amedro; M C Picot; S Moniotte; R Dorka; H Bertet; S Guillaumont; C Barrea; M Vincenti; G De La Villeon; C Bredy; C Soulatges; M Voisin; S Matecki; P Auquier Journal: Int J Cardiol Date: 2015-11-10 Impact factor: 4.164
Authors: Catherine Acquadro; Donald L Patrick; Sonya Eremenco; Mona L Martin; Dagmara Kuliś; Helena Correia; Katrin Conway Journal: J Patient Rep Outcomes Date: 2018-02-21
Authors: Pascal Amedro; Oscar Werner; Hamouda Abassi; Aymeric Boisson; Luc Souilla; Sophie Guillaumont; Johanna Calderon; Anne Requirand; Marie Vincenti; Victor Pommier; Stefan Matecki; Gregoire De La Villeon; Kathleen Lavastre; Alain Lacampagne; Marie-Christine Picot; Constance Beyler; Christophe Delclaux; Yves Dulac; Aitor Guitarte; Philippe Charron; Isabelle Denjoy-Urbain; Vincent Probst; Alban-Elouen Baruteau; Philippe Chevalier; Sylvie Di Filippo; Jean-Benoit Thambo; Damien Bonnet; Jean-Luc Pasquie Journal: Health Qual Life Outcomes Date: 2021-07-28 Impact factor: 3.186